Epithalon

Epitalon (Ala-Glu-Asp-Gly, AEDG) has produced telomere-related changes in cultured human cells, including a 2025 independent laboratory report. Those experiments do not show longer human life or safe clinical use; controlled human efficacy and exposure data remain unavailable.

Epitalon · Epithalone · AEDG peptide

Research evidence

Low

Cell and animal findings; no administered-human efficacy study among the cited works.

Preclinical: 73%
Human research: 0%

Based on 11 cited sources

11 visible records: nine publications, one FDA record and one published correction. Eight original preclinical papers include treated human cells, not treated patients. The correction is a separate record, not an additional experiment.

Identity

Also Known As

Epitalon • Epithalone • AEDG peptide

Class

Tetrapeptide

Length

4 amino acids

Mol. weight

390.35 Da

Sequence

AEDG

Molecular Structure

Hydrophobic

Polar

Positive

Negative

Epitalon, also called Epithalon, is the synthetic Ala-Glu-Asp-Gly (AEDG) tetrapeptide. It is distinct from pineal extracts and from other peptide bioregulators. Its best-cited telomere results come from cultured cells, not from treated people.

Telomere experiments

A 2003 study reported telomerase activity and telomere elongation after adding AEDG to telomerase-negative human fetal fibroblast cultures. A 2025 independent study reported hTERT/telomerase-associated telomere lengthening in normal cultured human cells and alternative-lengthening-of-telomeres activity in breast-cancer cell lines. The latter observation raises a mechanistic safety question; it does not prove an increase in cancer risk in humans. A published correction replaced incorrect Figures 1–3 in the 2025 paper; the corrected figures should be used when appraising its results. Neither study establishes longer lifespan, improved sleep or clinical benefit. PMID:12937682 · PMID:40908429 · Correction

Earlier animal and experimental work on chromatin, pineal-related and antioxidant measures is hypothesis-generating. It cannot be turned into a human anti-aging timeline or a claim that AEDG safely activates telomerase in a whole person. Studies of cultured human cells are preclinical studies, not human treatment trials.

Human evidence and safety boundary

No controlled human efficacy study showing improved lifespan, healthspan or sleep was identified. FDA’s compounding review reports insufficient safety-related information for the proposed administration route and cites potential immunogenicity from aggregation and peptide-related impurities. Combination effects with other peptides are unknown. FDA compounding safety review

i. Telomerase Activation Pathway · Cultured-Cell Telomeres

EpithalonEpigenetic ModulationhTERT Gene Transcription ↑Telomerase Reverse Transcriptase (TERT) ↑Telomerase Enzyme AssemblyTelomere-length change in cultured cells

ii. Chromatin Remodeling Pathway · Gene Expression

EpithalonHistone Interactions (H1, H2b, H3, H4)Heterochromatin DecondensationExperimental chromatin and gene-expression changes